3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
7
Hodgkin Disease
6
Lymphoma, Large B-Cell, Diffuse
5
Triple Negative Breast Neoplasms
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Lymphoma
4
Rhabdomyosarcoma
3
Lymphoma, Non-Hodgkin
3
Leukemia
3
Burkitt Lymphoma
3
Sarcoma
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Ovarian Neoplasms
2
Neuroblastoma
2
Multiple Myeloma
2
Fallopian Tube Neoplasms
2
Carcinoma, Ovarian Epithelial
2
Carcinoma, Non-Small-Cell Lung
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Teratoma
1
Squamous Cell Carcinoma of Head and Neck
1
Sleep Initiation and Maintenance Disorders
1
Sarcoma, Ewing
1
Renal Pelvis and Ureter Urothelial Carcinoma
1
Recurrence
1
Prostatic Neoplasms
1
Pheochromocytoma
1
Pancreatic Neoplasms
1
Pain
1
Interventions
Methylprednisolone
3
Social Determinants of Health
2
trastuzumab deruxtecan
1
sacituzumab govitecan
1
pegaspargase
1
Vincristine
1
Temozolomide
1
Radiotherapy
1
Prednisone
1
Prednisolone
1
Pharmaceutical Services
1
Methylprednisolone Hemisuccinate
1
Methotrexate
1
Mercaptopurine
1
Leucovorin
1
Irinotecan
1
Infliximab
1
Hydrocortisone
1
Fecal Microbiota Transplantation
1
Etoposide
1
Drug Therapy
1
Doxorubicin
1
Dexrazoxane
1
Dexamethasone
1
Cytarabine
1
Cyclophosphamide
1
Cefixime
1
CTLA-4 Antigen
1
Asparaginase
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Drug-Related Side Effects and Adverse Reactions
×
pegfilgrastim
×
1 year
×
Clear all
No trials found.